$0.50 target price?Seeking Alpha Summary posted today - Interesting (and very worrisome) take on the company. Management team has no industry experience & a history riddled with blunders; Poor governance all around - hiring a rent-a-CFO & associations with a known stock promoter. Aurora suggests they are building the worlds largest grow opFALSE! How much product are they really producing vs buying? It is not (and will not be) a low cost producer. Poor capital allocation has cost shareholders ~33% of its value (for consideration that likely retains no value):20m shares given away are just the tip of the iceberg (worth ~$47m). After giving away 43% of the PF company in an RTO, Aurora spent $37.5M (4.5x last financings valuation) on a patient aggregator that seems defunct and has limited future value. Industry valuation looks silly, even to insiders. $0.50 target price reflects 79% downside (still 25% above the $0.40 raise a little over four months ago). Summary: target price of $0.50/share; why Aurora's stock maintains 79% downside A stock appreciation in value usually boils down to a few reasons including but not limited to strong management, a growing industry and continued improvements to the underlying fundamental story. Aurora Cannabis Inc.'s stock (TSXV:ACB, OTC: ACBFF) stock has appreciated above and beyond its own wildest dreams despite significant execution risks, management histories riddled with blunders, questionable press and one poor capital allocation decision after another. The end result has been limited creation of shareholder value alongside consistent and rampant dilution. The Grumpy Bear fears for the potentially over exaggerated suggestions made by the company. Caveat Emptor!